UniPharma Co., Ltd.

NT$12.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6621Healthcare
Country Taiwan
PE (Fwd) •••
TSR 9Y CAGR (7.76%)
Div yield —
ROE (17.90%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.28)
PE TTM —
TSR TTM (0.83%)
Mkt cap NT$426.0M
ROIC (45.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$14
16.16%
(61.39%)
Hold 3|4|7|9|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.12
0.11
0.12
0.12
(4.13%)
(6.77%)
0.04%
7.44%
RevenueNT$M
27.91
28.52
29.00
29.39
13.27%
9.34%
11.98%
9.63%
Peers (US$12.87M)
Cap (US$)
PE
18.13M
1.110x
Capital
TTM
5Y
10Y
Leveragex
1.080
0.544
0.351
EBIT/Intx
17.14
0.114
0.095
Own earn%
416.18
153.71
151.03
Sh yield%
35.24
57.57
55.96
Owners
Insiders/Inst%
14.51
60.10
Short interest%
3.43
SBC / revenue%
2.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
7–12
$1 testx
—
Incr. ROIC%
2